EviCore’s updated coverage guidelines support access to AI-enabled Plaque Analysis to help physicians precisely diagnose and manage patients with coronary artery diseaseMOUNTAIN VIEW, Calif., July 11, ...

Researchers from The University of Western Australia, working with medtech industry partners Artrya, have developed a new, ...

Hollywood has shaped how many people imagine a heart attack—someone clutching their chest and collapsing dramatically. But ...

Elucid, an AI medical technology company focused on providing physicians with a more precise view of atherosclerosis to drive ...

Development and progression of coronary atherosclerotic lesions is mediated by a number of cellular components that are not readily visualized using the current clinical investigation tools.

4 Association between computed tomography features of non-alcoholic fatty liver disease and coronary artery disease: a sub-study of the scot-heart trial ...

New study details gaps between actual and recommended use of statins and other lipid-lowering drugs—and estimates public ...

Heartflow, Inc., the leader in AI technology for coronary artery disease (CAD), today announced it will present new data and technology ...

June 30, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc., the leader in AI technology for coronary artery disease (CAD), today announced ... change in over half of patients beyond coronary computed ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

NY Valves 2025 Up Next Presentation NY Valves 2025 Cardiac CTA for LAAC Planning (Transseptal Puncture and Procedural Strategy) Presenter: Omar K. Khalique More slides + ...

This paper is part of a series of expert consensus documents covering all aspects of aviation cardiology. In this manuscript, we focus on the broad aviation medicine considerations that are required ...